APOE and Alzheimer disease: In the ADNI cohort, among all participants, including those with CN, MCI, and AD, low ALT levels were significantly associated with faster longitudinal decline in memory function (β [SE] = 0.002 [0.001], p = 0.023) in the APOE ε4 carrier group after adjustment for multiple comparisons (Table 9).